Jonas Wang

Dr. Wang is in charge of healthcare and biotech investment and works out of our Princeton office.

Prior to joining Sycamore, Dr. Wang was Vice President of Research and Technology at Johnson & Johnson Consumer Products and a Corporate Director of J&J Drug Delivery Technology Resource Center (TRC), responsible for new product technology, patent strategy, competitive intelligence, and new measurement methodology for skin and hair care franchise. Prior to joining J&J, he was an Associate Director of Basic Pharmaceutics with the Pharmaceutical Research Institute of Bristol-Myers Squibb Company.

In 2001, he participated at the Congressional Business Summit in Washington, D. C., leading the group exploring emerging markets in America. Dr. Wang has over 30 years of experience in pharmaceutical R&D management and business development. He was also a member of J&J Consumer Product Worldwide’s Licensing & Acquisition Committee and was the key driver for several major acquisitions. He has published extensively in drug delivery technology and received several awards in his field, including the Johnson Medal, the highest technical achievement award at J&J, for one of his inventions: anti-wrinkle cream; the Distinguished Alumni awards from the National Defense Medical Center and University of Iowa. During his career with J&J, Dr. Wang developed more than 10 core technologies, and filed more than 30 business-related patents. He is currently a member of the Boards of Directors of StemCyte, Inc., Epitomics, Inc. U-Systems, Inc., and AGT-YNBY, and is also a Board observer of Transave Inc.and Cardiva Medical, Inc.

Dr. Wang received his Ph.D. in Physical Pharmacy from University of Iowa, USA and Pharmacy degree from National Defense Medical Center in Taiwan, Republic of China.